VJHemOnc Podcast cover image

Highlights from iwMyeloma 2025: trial updates and practical considerations

VJHemOnc Podcast

00:00

Advancements in Myeloma Treatment

This chapter explores the latest updates on antibody-drug conjugates, specifically Belantimab Mafodotin, and its role in treating multiple myeloma. It discusses the evolving landscape of bispecific therapies, upcoming FDA approvals, and the impact of new technologies on disease classification and treatment optimization.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app